Our results suggest that mitochondrial alterations in CD8+ T cells are associated with treatment responsiveness in depressed patients, and may reflect immune-metabolic changes that accompany the low-grade inflammatory state observed in depression. The gene discussed is CD8A; the disease is depressive symptom measurement.